 |
|
Role of the Metabolic Syndrome in Risk Assessment for Coronary Heart Disease
Commentary by Priya Kohli, MD;
Philip Greenland, MD
JAMA. 2006;295(7):819-821.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
ARCHIVES OF INTERNAL MEDICINE
Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus
S. Goya Wannamethee, PhD; A. Gerald Shaper, FRCP; Lucy Lennon, MSc; Richard W. Morris, PhD
Background: We sought to compare metabolic syndrome (MetS) with the Framingham Risk Score (FRS) as predictors of coronary heart disease (CHD), stroke, and type 2 diabetes mellitus (DM2) in middle-aged men.
Methods: A prospective study of 5128 men aged 40 to 59 years with no history of cardiovascular disease (CVD) (CHD or stroke) or DM2 drawn from general practices in 24 British towns and observed for 20 years. Metabolic syndrome was defined as the presence of 3 or more metabolic abnormalities based on modified National Cholesterol Education Program criteria.
Results: Men with MetS at baseline (26%) showed significantly higher relative risk (RR) than men without . . . [Full Text of this Article]
Author Affiliations: Northwestern Memorial Hospital (Dr Kohli) and Department of Preventive Medicine, Northwestern University Feinberg School of Medicine (Dr Greenland), Chicago, Ill. Dr Greenland is the Editor, Archives of Internal Medicine.
RELATED ARTICLES
The Metabolic Syndrome
Janet M. Torpy, Cassio Lynm, and Richard M. Glass
JAMA. 2006;295(7):850.
EXTRACT
| FULL TEXT
Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus
S. Goya Wannamethee, A. Gerald Shaper, Lucy Lennon, and Richard W. Morris
Arch Intern Med. 2005;165(22):2644-2650.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Insulin Resistance, Metabolic Syndrome, and Subclinical Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)
Bertoni et al.
Diabetes Care 2007;30:2951-2956.
ABSTRACT
| FULL TEXT
Metabolic Syndrome: Is It a Syndrome? Does It Matter?
Kahn
Circulation 2007;115:1806-1811.
FULL TEXT
Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome
Bochud et al.
Hypertension 2006;48:239-245.
ABSTRACT
| FULL TEXT
The Metabolic Syndrome (Emperor) Wears No Clothes
Kahn
Diabetes Care 2006;29:1693-1696.
FULL TEXT
|
